Peptide COAs

Ipamorelin

59 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.

Public certificates

Approved community and directory-linked COAs only.

  • Ipamorelin + Ipamorelin - 10mg

    Brand not listed · Jul 28, 2026 · Core panels 100% · 3/7 panels · 99.9% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns92Doc score
  • CJC/Ipamorelin 10mg + CJC-125 5 + Ipamorelin + CJC-125 (No DAC)

    American Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • CJC-1295 (No DAC) + Ipamorelin

    American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • Ipamorelin

    American Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • Ipamorelin + CJC-1295

    Crush Research · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.83% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • Ipamorelin + CJC-1295

    Crush Research · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • Ipamorelin

    Crush Research · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.8% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • Ipamorelin

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.71% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • Ipamorelin

    Crush Research · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • Ipamorelin

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.36% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Ipamorelin

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Ipamorelin

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.25% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Ipamorelin

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.36% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Ipamorelin

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.25% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Ipamorelin

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.77% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.74% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + Ipamorelin 10mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.95% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.712% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + Ipamorelin 10mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.657% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.597% purity · Doc 62

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295 (NO DAC)

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.95% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295 (no DAC)

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.64% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.54% purity · Doc 68

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.928% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295 + Ipamorelin + CJC-1295 no DAC

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin + CJC-1295 no DAC

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.13% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.989% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.711% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin + CJC-1295

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin + CJC-1295 (No DAC)

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.93% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • CJC-1295 no DAC + Ipamorelin + Tesamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.825% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin + CJC-1295 (no DAC)

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.939% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.92% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.65% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin + CJC-1295

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.84% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin + CJC-1295 (No DAC)

    Peptide Partners · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Ipamorelin

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.84% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Ipamorelin

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.68% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Ipamorelin

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Ipamorelin

    Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.95% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Ipamorelin

    Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Tesamorelin + Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.93% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.85% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.94% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.85% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    BioLongevity Labs · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.85% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns59Mixed signals
  • Ipamorelin

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.926% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • CJC-IPA + CJC-1295 + Ipamorelin

    Lumira · Sep 5, 2026 · Core panels 100% · 4/7 panels · 98.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • CJC-1295 + Ipamorelin

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.14% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • Ipamorelin

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.5% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • IPAMORELIN

    Paramount Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.83% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • CJC-1295 + Ipamorelin

    Brand not listed · Jul 28, 2026 · Core panels 33% · 1/7 panels

    Multiple signals on this document conflict with known lab formats or verification patterns.

    Evidence suggests fabrication15Doc score

Community-sourced

Help build the COA record

PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.

Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.

Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.